GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » 1-Year ROIIC %

Tauns Laboratories (TSE:197A) 1-Year ROIIC % : 87.53% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Tauns Laboratories's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was 87.53%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Tauns Laboratories's 1-Year ROIIC % or its related term are showing as below:

TSE:197A's 1-Year ROIIC % is ranked better than
79.98% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 1.79 vs TSE:197A: 87.53

Tauns Laboratories 1-Year ROIIC % Historical Data

The historical data trend for Tauns Laboratories's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories 1-Year ROIIC % Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
1-Year ROIIC %
- -64.61 87.53

Tauns Laboratories Semi-Annual Data
Jun22 Jun23 Jun24
1-Year ROIIC % - -64.61 87.53

Competitive Comparison of Tauns Laboratories's 1-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's 1-Year ROIIC % falls into.



Tauns Laboratories 1-Year ROIIC % Calculation

Tauns Laboratories's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 5918.182226 (Jun. 2024) - 3238.665908 (Jun. 2023) )/( 18513.102 (Jun. 2024) - 15451.687 (Jun. 2023) )
=2679.516318/3061.415
=87.53%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Tauns Laboratories  (TSE:197A) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Tauns Laboratories 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines